Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Rx Drugs

March 22, 2020 | Daily News

The Senate GOP’s third coronavirus stimulus bill includes several Medicare and Medicaid extenders, which jeopardizes the surprise billing and drug pricing policies that were excluded.

March 19, 2020 | Daily News

Medical device makers would be required to report potential device shortages or supply disruptions to FDA should Congress pass the Senate’s latest coronavirus stimulus bill, which also includes expanded drug shortage reporting requirements for drug makers.

March 19, 2020 | Daily News

FDA hopes to use its compassionate use program to get potential COVID-19 therapies to health care providers and patients while also gathering information on safety and efficacy, agency chief Stephen Hahn announced Thursday (March 19) during a White House press briefing.

March 19, 2020 | Daily News

FDA has postponed all routine domestic facility inspections in order to protect the health and well-being of agency staff and to address industry’s concern over visitors, FDA announced Wednesday (March 18), coming as the Trump administration advises against unnecessary travel due to the nationwide spread of COVID-19.

March 19, 2020 | Daily News

FDA issued a guidance on Wednesday (March 18) offering flexibility around clinical trial policies in a bid to maintain patient safety and test integrity amid the challenges posed by the COVID-19 pandemic, including the possibility of virtual and phone visits for trial participants.

March 19, 2020 | Daily News

Pharmacies are asking the federal government to grant them permission in Medicare to take on services that doctors typically provide to help adjust to shortages and alleviate pressure that the coronavirus is expected to exert on hospitals and doctors' offices.

March 19, 2020 | Daily News

White House trade adviser Peter Navarro’s push to “reshore” the pharmaceutical and medical supplies supply chain is unrealistic and ultimately will cause more harm than good to Americans, a Chinese foreign ministry spokesman said on Tuesday.

March 18, 2020 | Daily News

The U.S. Chamber of Commerce this week established a task force to address supply chain and trade disruptions caused by the coronavirus outbreak.

March 16, 2020 | Daily News

The National Institutes of Health announced the launch of the world's first COVID-19 vaccine trial on Monday (March 16).

March 12, 2020 | Daily News

Democratic primary candidates Sen. Bernie Sanders (VT) and former Vice President Joe Biden both proposed the U.S. government prevent pharmaceutical companies from price gouging patients for critical supplies during the coronavirus outbreak and make testing, vaccines and treatments free of charge.

March 11, 2020 | Daily News

FDA drug center chief Janet Woodcock argued against revealing the names of drugs that are in shortage because of the COVID-19 pandemic, saying not only is the agency not allowed to share that information but that revealing it would confuse those who aren’t experts in the drug space and could create panic.

March 11, 2020 | Daily News

As the spread of coronavirus places a spotlight on long-standing issues in the pharmaceutical supply chain and lawmakers seek solutions, the newest drug shortage bill, House Energy & Commerce Committee member Scott Peters’ (D-CA) Preventing Drug Shortages Act (H.R. 6080), brings together bipartisan ideas that a policy expert says would help address supply issues during the outbreak by increasing supply chain transparency and reporting.

March 11, 2020 | Daily News

House Energy & Commerce Committee leaders from both parties have requested FDA brief them by March 23 on the effect the coronavirus outbreak has had on the drug and device supply chain and on how the agency plans to combat potential shortages.

March 11, 2020 | Daily News

FDA on Tuesday (March 10) officially reopened its April 2019 cannabidiol comment docket on Regulations.gov in order to gather up-to-date information on CBD as it crafts regulations and determines whether to allow the compound to be used in consumer products, including foods and dietary supplements.

March 11, 2020 | Daily News

Sen. Mark Warner (D-VA) and HHS Secretary Alex Azar both sounded the alarm that the United States could face drug shortages during the outbreak of the novel coronavirus, due to our reliance on foreign-made pharmaceutical products and supplies.

March 11, 2020 | Daily News

COVID-19 vaccines and drugs would likely be covered at little to no cost for most people and the government has more leverage over the price of emergency countermeasures than it has over drug prices in Medicare, Medicaid and the commercial market, sources say.

March 10, 2020 | Daily News

FDA postponed all of its foreign inspections, effective immediately, until April, FDA chief Stephen Hahn announced Tuesday (March 10) -- coming amid a wave of event and meeting cancellations throughout the United States as coronavirus spreads throughout the country, and as other countries mandate quarantines.

March 10, 2020 | Daily News

The House Energy & Commerce health subcommittee will mark up a wide-ranging slate of bills on Wednesday (March 11), committee Chair Frank Pallone (D-NJ) and subcommittee Chair Anna Eshoo (D-CA) announced Monday.

March 09, 2020 | Daily News

The Center for Science in the Public Interest applauded FDA and the Federal Trade Commission for taking action against seven companies, including The Jim Bakker Show, for selling teas, essential oils, tinctures and colloidal silver with claims the products can cure, treat or prevent coronavirus.

March 06, 2020 | Daily News

Democratic senators are demanding HHS immediately reverse actions that have undermined the Affordable Care Act and other policies that could impede consumers’ ability to get coverage amid the coronavirus outbreak, and pledge to ensure any coronavirus vaccine will be affordable.

Pages